CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,684,000 | -43.0% | 259,599 | -50.0% | 4.64% | -56.4% |
| Q2 2020 | $38,062,000 | +73.4% | 519,198 | 0.0% | 10.64% | -27.0% |
| Q1 2020 | $21,952,000 | -30.6% | 519,198 | 0.0% | 14.58% | -4.6% |
| Q4 2019 | $31,619,000 | +22.8% | 519,198 | -17.4% | 15.28% | -6.1% |
| Q3 2019 | $25,745,000 | -53.2% | 628,398 | -46.3% | 16.28% | -22.9% |
| Q2 2019 | $55,050,000 | +31.6% | 1,171,268 | 0.0% | 21.11% | -43.6% |
| Q1 2019 | $41,826,000 | +25.0% | 1,171,268 | 0.0% | 37.43% | +23.1% |
| Q4 2018 | $33,463,000 | -39.0% | 1,171,268 | -5.3% | 30.40% | -6.8% |
| Q3 2018 | $54,858,000 | -24.5% | 1,237,202 | 0.0% | 32.62% | -21.5% |
| Q2 2018 | $72,698,000 | -15.7% | 1,237,202 | -34.4% | 41.53% | -22.5% |
| Q1 2018 | $86,207,000 | +88.2% | 1,887,202 | -3.3% | 53.59% | +61.5% |
| Q4 2017 | $45,798,000 | +30.3% | 1,951,359 | -1.0% | 33.18% | +36.4% |
| Q3 2017 | $35,139,000 | -9.8% | 1,971,907 | -19.3% | 24.33% | -21.6% |
| Q2 2017 | $38,970,000 | -31.2% | 2,444,809 | -6.0% | 31.01% | -26.5% |
| Q1 2017 | $56,641,000 | +8.8% | 2,601,814 | 0.0% | 42.20% | -3.0% |
| Q4 2016 | $52,036,000 | – | 2,601,814 | – | 43.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,608,874 | $160,053,562,000 | 54.44% |
| Abingworth LLP | 1,237,202 | $54,858,000 | 32.62% |
| NEA Management Company, LLC | 2,090,678 | $92,722,000 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 444,708 | $19,723,000 | 3.59% |
| EcoR1 Capital, LLC | 500,000 | $22,175,000 | 2.00% |
| ARK Investment Management | 1,453,590 | $64,467,000 | 1.95% |
| CLOUGH CAPITAL PARTNERS L P | 337,731 | $14,978,000 | 1.41% |
| Casdin Capital, LLC | 220,000 | $9,757,000 | 1.19% |
| Valiant Capital Management, L.P. | 271,700 | $12,050,000 | 1.07% |
| Monashee Investment Management LLC | 110,000 | $4,879,000 | 1.03% |